| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.21 | 7e-10 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.2 | 7e-09 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-08 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.2 | 4e-08 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-08 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-07 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.22 | 2e-06 |